These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 18788502)
61. Selection of response criteria for clinical trials of sarcoma treatment. Schuetze SM; Baker LH; Benjamin RS; Canetta R Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637 [TBL] [Abstract][Full Text] [Related]
62. Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. Basu S; Zaidi H; Houseni M; Bural G; Udupa J; Acton P; Torigian DA; Alavi A Semin Nucl Med; 2007 May; 37(3):223-39. PubMed ID: 17418154 [TBL] [Abstract][Full Text] [Related]
63. Response criteria in oncologic imaging: review of traditional and new criteria. Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927 [TBL] [Abstract][Full Text] [Related]
64. Radiological monitoring of the treatment of solid tumors in practice. Ganten MK; Ganten TM; Schlemmer HP Rofo; 2014 May; 186(5):466-73. PubMed ID: 24563412 [TBL] [Abstract][Full Text] [Related]
65. PET/CT for the staging and follow-up of patients with malignancies. Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595 [TBL] [Abstract][Full Text] [Related]
66. Response assessment in clinical trials: implications for sarcoma clinical trial design. Jaffe CC Oncologist; 2008; 13 Suppl 2():14-8. PubMed ID: 18434633 [TBL] [Abstract][Full Text] [Related]
67. Integrated PET/CT and cancer imaging. De Wever W; Coolen J; Verschakelen JA JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480 [TBL] [Abstract][Full Text] [Related]
68. Whole-body MRI for the staging and follow-up of patients with metastasis. Schmidt GP; Reiser MF; Baur-Melnyk A Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631 [TBL] [Abstract][Full Text] [Related]
69. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215 [TBL] [Abstract][Full Text] [Related]
71. [18F]FDG-PET-CT for early monitoring of tumor response: when and why. Storto G; Nicolai E; Salvatore M Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):167-80. PubMed ID: 19293765 [TBL] [Abstract][Full Text] [Related]
72. Noninvasive assessment of coronary anatomy and myocardial perfusion: going toward an integrated imaging approach. Petretta M; Costanzo P; Acampa W; Imbriaco M; Ferro A; Filardi PP; Cuocolo A J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):977-86. PubMed ID: 18799959 [TBL] [Abstract][Full Text] [Related]
73. [A summary report of response evaluation criteria in solid tumors (RECIST criteria)]. Kusaba H; Saijo N Gan To Kagaku Ryoho; 2000 Jan; 27(1):1-5. PubMed ID: 10660728 [TBL] [Abstract][Full Text] [Related]